Correlation Between ELYM Old and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both ELYM Old and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ELYM Old and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ELYM Old and Ikena Oncology, you can compare the effects of market volatilities on ELYM Old and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ELYM Old with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ELYM Old and Ikena Oncology.
Diversification Opportunities for ELYM Old and Ikena Oncology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ELYM and Ikena is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ELYM Old and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and ELYM Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ELYM Old are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of ELYM Old i.e., ELYM Old and Ikena Oncology go up and down completely randomly.
Pair Corralation between ELYM Old and Ikena Oncology
If you would invest (100.00) in ELYM Old on December 19, 2024 and sell it today you would earn a total of 100.00 from holding ELYM Old or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ELYM Old vs. Ikena Oncology
Performance |
Timeline |
ELYM Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Ikena Oncology |
ELYM Old and Ikena Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ELYM Old and Ikena Oncology
The main advantage of trading using opposite ELYM Old and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ELYM Old position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.The idea behind ELYM Old and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |